AKT1 and renal carcinoma: Using renal cancer cell lines, Shen et al. demonstrated that miR-188-5p inhibits the proliferation and invasion of renal cancer cells by downregulating myristoylated alanine-rich C-kinase substrate (MARCKS) expression and inhibiting the AKT/mTOR signalling pathway [119].